|
|
Article: Circassia Acquires North American and Japanese Rights to Dopexamine.
- Article from:
- PR Newswire
- Article date:
- October 8, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Circassia Establishes Commercial-Scale Supply Chain
Circassia to Develop Dopexamine as Part of Proprietary Post-Surgery Recovery Protocols
OXFORD, England, October 8 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on the fields of allergy and critical care, announced today that it has acquired the US, Canadian and Japanese development and commercialization rights to dopexamine from the international speciality pharmaceutical company Ipsen. Circassia has also entered into agreements with pharmaceutical manufacturers Excella and Hospira to establish a commercial-scale supply chain for the product.
Circassia is ...